Rethinking Extended VTE Chemoprophylaxis After Pancreatectomy for Cancer: Is the Current Subcutaneous Approach Effective?
Highlight
– Extended 28-day venous thromboembolism (VTE) chemoprophylaxis with once-daily subcutaneous enoxaparin is standard after pancreatectomy for malignancy.
– This large single-institution retrospective analysis found no significant reduction in symptomatic postoperative VTE rates with extended prophylaxis.
– Higher body mass index (BMI) independently predicts increased risk of VTE after hospital discharge despite prophylaxis.
– Findings highlight the inadequacy of current prophylaxis dosing and underscore the potential need for weight-based VTE prevention strategies.
Study Background
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.